SCHEMBL577153

SCHEMBL577153

Cc1ccc([NH3+])c(C)c1C.c1ccc([B-](c2ccccc2)(c2ccccc2)c2ccccc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.33
CYP2A6 P11509 1/20 0.33
TSHR P16473 1/20 0.33
LMNA P02545 1/20 0.30
TP53 P04637 1/20 0.30
MAPT P10636 1/20 0.30
THRB P10828 1/20 0.30
RECQL P46063 1/20 0.30
BLM P54132 1/20 0.30
ATM Q13315 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1899051 0.84 TRPA1 (0.35) CYP1A2CYP2A6TSHRLMNAATM
SCHEMBL384000 0.76 CYP1A2 (0.30) CYP1A2CYP2A6TSHR
SCHEMBL2833074 0.76 CYP3A4 (0.39) CYP1A2CYP2A6TSHRLMNAMAPT
Methylamine SCHEMBL3628885 0.72 ALDH1A1 (0.41) CYP1A2TSHRLMNATP53MAPT
SCHEMBL7455791 0.71 ACHE (0.31)
SCHEMBL2125235 0.71 TRPA1 (0.34) CYP1A2CYP2A6TSHRATM
SCHEMBL577778 0.71
Methoxymethane SCHEMBL7627878 0.70 ALDH1A1 (0.39) TSHRLMNATP53MAPTTHRB
SCHEMBL8022933 0.69 TRPA1 (0.37) CYP1A2CYP2A6TSHRLMNATP53
SCHEMBL7185976 0.69 CYP1A2 (0.38) CYP1A2CYP2A6TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 314 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5444134-A Using a coordination catalyst IDEMITSU KOSAN CO., LTD. (JP) 1995-08-22 US claimed
US-20240308936-A1 METHOD FOR PRODUCING ALPHA-OLEFIN OLIGOMER COMPOSITION IDEMITSU KOSAN CO.,LTD. (JP) 2024-09-19 US disclosed
EP-4385972-A1 METHOD FOR PRODUCING ALPHA-OLEFIN OLIGOMER COMPOSITION Idemitsu Kosan Co.,Ltd. (JP) 2024-06-19 EP disclosed
WO-2024116789-A1 LUBRICATING OIL COMPOSITION 出光興産株式会社 2024-06-06 WO disclosed
EP-3626869-B1 CRIMPED FIBERS AND NONWOVEN CLOTH IDEMITSU KOSAN CO (JP) 2024-04-24 EP disclosed
WO-2024080214-A1 METHOD FOR PRODUCING α-OLEFIN POLYMER 出光興産株式会社 2024-04-18 WO disclosed
US-20230235202-A1 PLASTICIZER FOR RESINS IDEMITSU KOSAN CO.,LTD. (JP) 2023-07-27 US disclosed
WO-2023017779-A1 METHOD FOR PRODUCING α-OLEFIN OLIGOMER COMPOSITION 出光興産株式会社 2023-02-16 WO disclosed
CN-110494486-B Polypropylene resin composition, pellet, and molded article 出光兴产株式会社 2022-08-26 CN disclosed
US-11034826-B2 Polypropylene-based resin composition, pellet, and molded object IDEMITSU KOSAN CO., LTD. (JP) 2021-06-15 US disclosed
EP-0590486-A2 Polymerization catalysts and process for producing polymers IDEMITSU KOSAN COMPANY LIMITED (JP) 1994-04-06 EP disclosed
EP-0571987-A2 Process for producing an ethylenic polymer composition IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-12-01 EP disclosed
EP-0572003-A2 Process for producing an ethylenic polymer composition IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-12-01 EP disclosed
EP-0572034-A2 Ethylenic copolymer and ethylenic copolymer composition IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-12-01 EP disclosed
EP-0570931-A2 Styrenic polymer, process for producing same and multi-layer material comprising same IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-11-24 EP disclosed
EP-0570932-A2 Styrenic block copolymer and process for producing same IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-11-24 EP disclosed
EP-0559108-A1 Graft copolymer, process for production thereof and resin composition containing same IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-09-08 EP disclosed
EP-0522581-A1 Process for producing olefin based polymers and olefin polymerization catalyst IDEMITSU KOSAN COMPANY LIMITED (JP) 1993-01-13 EP disclosed
EP-0513380-A1 PROCESS FOR PRODUCING OLEFINIC POLYMER IDEMITSU KOSAN COMPANY LIMITED (JP) 1992-11-19 EP disclosed
EP-0504418-A1 PROCESS FOR PRODUCING CYCLOOLEFIN POLYMER, CYCLOOLEFIN COPOLYMER, AND COMPOSITION AND MOLDING PREPARED THEREFROM IDEMITSU KOSAN COMPANY LIMITED (JP) 1992-09-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240308936-A1 METHOD FOR PRODUCING ALPHA-OLEFIN OLIGOMER COMPOSITION OXER1, AMY1A, MACF1 CYP1A2 593/4885CYP2A6 1150/4885TSHR 4330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.